Form 4: Biolife Solutions Executive Receives Stock Grant

Sentiment:

Insider Transaction (Form 4)


Aby J. Mathew, EVP & Chief Scientific Officer of Biolife Solutions Inc, reported multiple transactions in common stock on October 6, 2026.

Summary

  • Grant/award: acquired 45,838 Common Stock on October 6, 2026; holds 343,866 after (Direct).
  • Grant/award: acquired 40,192 Common Stock on October 6, 2026; holds 384,058 after (Direct).
  • Tax/exercise-price withholding: disposed of 70,000 Common Stock at $38.61 ($2,702,700) on October 6, 2026; holds 314,058 after (Direct).
  • Disposition to the issuer: disposed of 404,608 Common Stock on October 6, 2026 (Direct).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.

Insider Transactions

Aby J. Mathew — Officer (EVP & Chief Scientific Officer)

DateTransactionSecuritySharesPriceValueHeld After
2026-10-06Grant/awardCommon Stock45,838——343,866
2026-10-06Grant/awardCommon Stock40,192——384,058
2026-10-06Tax/exercise-price withholdingCommon Stock70,000$39$2.7M314,058
2026-10-06Disposition to the issuerCommon Stock404,608——0

Key Dates

DateDescription
2026-10-06Grant/award (45,838 shares)
2026-10-06Grant/award (40,192 shares)
2026-10-06Tax/exercise-price withholding (70,000 shares)
2026-10-06Disposition to the issuer (404,608 shares)

Keywords

insider transaction, Form 4, BLFS, BIOLIFE SOLUTIONS INC, neutral, Aby J. Mathew

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.